178 related articles for article (PubMed ID: 35972577)
41. HULC functions as an oncogene in ovarian carcinoma cells by negatively modulating miR-125a-3p.
Chu P; Xu L; Su H
J Physiol Biochem; 2019 Jun; 75(2):163-171. PubMed ID: 30863948
[TBL] [Abstract][Full Text] [Related]
42. CircVAPA promotes small cell lung cancer progression by modulating the miR-377-3p and miR-494-3p/IGF1R/AKT axis.
Hua J; Wang X; Ma L; Li J; Cao G; Zhang S; Lin W
Mol Cancer; 2022 Jun; 21(1):123. PubMed ID: 35668527
[TBL] [Abstract][Full Text] [Related]
43. CELF2 suppresses non-small cell lung carcinoma growth by inhibiting the PREX2-PTEN interaction.
Yeung YT; Fan S; Lu B; Yin S; Yang S; Nie W; Wang M; Zhou L; Li T; Li X; Bode AM; Dong Z
Carcinogenesis; 2020 May; 41(3):377-389. PubMed ID: 31241130
[TBL] [Abstract][Full Text] [Related]
44. MiR-323-3p Targeting Transmembrane Protein with EGF-Like and 2 Follistatin Domain (TMEFF2) Inhibits Human Lung Cancer A549 Cell Apoptosis by Regulation of AKT and ERK Signaling Pathways.
Fan JM; Zheng ZR; Zeng YM; Chen XY
Med Sci Monit; 2020 Feb; 26():e919454. PubMed ID: 32009129
[TBL] [Abstract][Full Text] [Related]
45. LncRNA-SNHG16 promotes proliferation and migration of acute myeloid leukemia cells via PTEN/PI3K/AKT axis through suppressing CELF2 protein.
Shi M; Yang R; Lin J; Wei QI; Chen L; Gong W; Li Y; Guo X
J Biosci; 2021; 46():. PubMed ID: 33576342
[TBL] [Abstract][Full Text] [Related]
46. Exosome-depleted MiR-148a-3p derived from Hepatic Stellate Cells Promotes Tumor Progression via ITGA5/PI3K/Akt Axis in Hepatocellular Carcinoma.
Zhang X; Chen F; Huang P; Wang X; Zhou K; Zhou C; Yu L; Peng Y; Fan J; Zhou J; Lu Z; Hu J; Wang Z
Int J Biol Sci; 2022; 18(6):2249-2260. PubMed ID: 35414782
[TBL] [Abstract][Full Text] [Related]
47. MiR-141-3p is upregulated in esophageal squamous cell carcinoma and targets pleckstrin homology domain leucine-rich repeat protein phosphatase-2, a negative regulator of the PI3K/AKT pathway.
Ishibashi O; Akagi I; Ogawa Y; Inui T
Biochem Biophys Res Commun; 2018 Jun; 501(2):507-513. PubMed ID: 29738771
[TBL] [Abstract][Full Text] [Related]
48. MiR-203a-3p regulates the biological behaviors of ovarian cancer cells through mediating the Akt/GSK-3β/Snail signaling pathway by targeting ATM.
Liu HY; Zhang YY; Zhu BL; Feng FZ; Zhang HT; Yan H; Zhou B
J Ovarian Res; 2019 Jul; 12(1):60. PubMed ID: 31277702
[TBL] [Abstract][Full Text] [Related]
49. CELF2 is a candidate prognostic and immunotherapy biomarker in triple-negative breast cancer and lung squamous cell carcinoma: A pan-cancer analysis.
Wang L; Liu Z; Liu L; Guo C; Jiao D; Li L; Zhao J; Han X; Sun Y
J Cell Mol Med; 2021 Aug; 25(15):7559-7574. PubMed ID: 34288370
[TBL] [Abstract][Full Text] [Related]
50. Exploring the Study of miR-1301 Inhibiting the Proliferation and Migration of Squamous Cell Carcinoma YD-38 Cells through PI3K/AKT Pathway under Deep Learning Medical Images.
Gong C; Bhargava R; Bajaj C
Comput Intell Neurosci; 2022; 2022():5865640. PubMed ID: 35186067
[TBL] [Abstract][Full Text] [Related]
51. Hox transcript antisense RNA knockdown inhibits osteosarcoma progression by regulating the phosphoinositide 3-kinase/AKT pathway through the microRNA miR-6888-3p/spleen tyrosine kinase axis.
Wu W; Wang L; Li S
Bioengineered; 2022 Apr; 13(4):9397-9410. PubMed ID: 35435107
[TBL] [Abstract][Full Text] [Related]
52. H3K27ac-activated LINC00519 promotes lung squamous cell carcinoma progression by targeting miR-450b-5p/miR-515-5p/YAP1 axis.
Ye P; Lv X; Aizemaiti R; Cheng J; Xia P; Di M
Cell Prolif; 2020 May; 53(5):e12797. PubMed ID: 32297697
[TBL] [Abstract][Full Text] [Related]
53. MicroRNA-20a-5p suppresses tumor angiogenesis of non-small cell lung cancer through RRM2-mediated PI3K/Akt signaling pathway.
Han J; Hu J; Sun F; Bian H; Tang B; Fang X
Mol Cell Biochem; 2021 Feb; 476(2):689-698. PubMed ID: 33125611
[TBL] [Abstract][Full Text] [Related]
54. MiR-4299 suppresses non-small cell lung cancer cell proliferation, migration and invasion through modulating PTEN/AKT/PI3K pathway.
Yang WB; Zhang WP; Shi JL; Wang JW
Eur Rev Med Pharmacol Sci; 2018 Jun; 22(11):3408-3414. PubMed ID: 29917192
[TBL] [Abstract][Full Text] [Related]
55. NPHS2-6 drives cervical squamous cell carcinoma (CSCC) progression via hsa-miR-1323/SMC1B axis to activate PI3K-Akt pathway.
Li F; Wang Y; Wen M; Aizezi G; Yuan J; Zhou T; Shen G
Clin Transl Oncol; 2024 Jan; 26(1):245-259. PubMed ID: 37322227
[TBL] [Abstract][Full Text] [Related]
56. miR-144-3p facilitates nasopharyngeal carcinoma via crosstalk with PTEN.
Song L; Chen L; Luan Q; Kong Q
J Cell Physiol; 2019 Aug; 234(10):17912-17924. PubMed ID: 30834525
[TBL] [Abstract][Full Text] [Related]
57. miR-133a-3p suppresses cell proliferation, migration, and invasion and promotes apoptosis in esophageal squamous cell carcinoma.
Yin Y; Du L; Li X; Zhang X; Gao Y
J Cell Physiol; 2019 Aug; 234(8):12757-12770. PubMed ID: 30537034
[TBL] [Abstract][Full Text] [Related]
58. Muscleblind-like 1 antisense RNA 1 inhibits cell proliferation, invasion, and migration of prostate cancer by sponging miR-181a-5p and regulating PTEN/PI3K/AKT/mTOR signaling.
Ding X; Xu X; He XF; Yuan Y; Chen C; Shen XY; Su S; Chen Z; Xu ST; Huang YH
Bioengineered; 2021 Dec; 12(1):803-814. PubMed ID: 33648424
[TBL] [Abstract][Full Text] [Related]
59. MicroRNA miR-23b-3p promotes osteosarcoma by targeting ventricular zone expressed PH domain-containing 1 (VEPH1)/phosphatidylinositol 3-kinase/protein kinase B (PI3K/AKT) pathway.
Fan L; Cao X; Lei Y
Bioengineered; 2021 Dec; 12(2):12568-12582. PubMed ID: 34903122
[TBL] [Abstract][Full Text] [Related]
60. miR-212-5p exerts tumor promoter function by regulating the Id3/PI3K/Akt axis in lung adenocarcinoma cells.
Chen FF; Sun N; Wang Y; Xi HY; Yang Y; Yu BZ; Li XJ
J Cell Physiol; 2020 Oct; 235(10):7273-7282. PubMed ID: 32039486
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
